Work

Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.3050.3050

Authors: Beata Holkova, Maciej Kmieciak, Prithviraj Bose, Shuo Ma, Amy Kimball, Mary Beth Tombes, Ellen Shrader, Wen Wan, Caryn Weir-Wiggins, Elizabeth Stoddert, Amanda Garnett Singh, April Dean, Sarah Conine, Heidi Sankala, John D. Roberts, Thomas C. Shea, Steven Grant

Institutions: VCU Massey Comprehensive Cancer Center, Northwestern University, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Yale University, University of North Carolina at Chapel Hill

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2544704661

FWCI: 1.35

Cites:

Cited by: 9

Related to: 10